Looks like you clickedhttps://www.biospace.com/article/releases/kairos-pharma-doses-first-patient-in-phase-2-trial-of-lead-drug-candidate-env105-with-apalutamide-to-improve-therapy-sensitivity-for-castrate-resistant-prostate-cancer/
If you do not want to visit that page, you can close this browser tab.
